NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Active Crohn's disease
Date of first enrollment	29/03/2011
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Z-206 INN of investigational material : Mesalazine Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : oral

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 16age old
Age maximum	<= 64age old
Gender	Both
Include criteria	CDAI score : 200 to less than 350 Patients in whom mucosal lesions are observed at the area between the terminal ileum and rectum outpatient
Exclude criteria